Notes
NCT02293395
References
Ohman EM, et al. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. Lancet : 18 Mar 2017. Available from: URL: http://doi.org/10.1016/S0140-6736(17)30751-1.
Gurbel PA, et al. GEMINI-ACS-1: toward unearthing the antithrombotic therapy cornerstone for acute coronary syndromes. Lancet : 27 Mar 2017. Available from: URL: http://dx.doi.org/10.1016/ S0140-6736(17)30760-2.
Rights and permissions
About this article
Cite this article
P2Y12 inhibition with aspirin or rivaroxaban: GEMINI-ACS-1 study. Reactions Weekly 1645, 12 (2017). https://doi.org/10.1007/s40278-017-28094-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-28094-9